We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-5.6%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$6.86M
Cap. Flow
+$42.9M
Cap. Flow %
33.14%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
TTOO
T2 Biosystems, Inc
TTOO
+$44.2M

Top Sells

Rank Stock Value
1
GNCA
Genocea Biosciences, Inc.
GNCA
+$1.01M
2
TRVN
Trevena, Inc.
TRVN
+$257K

Sector Composition

Rank Sector Weight
1 Healthcare 53.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTOO
1
DELISTED
T2 Biosystems, Inc
TTOO
$43M 33.15%
+475
New +$44.2M
TRVN
2
DELISTED
Trevena, Inc.
TRVN
$24.2M 18.68%
6,031
-68
-1% -$257K
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$18.6M 14.35%
256,904
-9,181
-3% -$1.01M
BIND
4
DELISTED
BIND THERAPEUTICS INC
BIND
$17.3M 13.38%
2,018,253
– –
DARE icon
5
Dare Bioscience
DARE
$17.4M
$13.9M 10.71%
27,396
– –
FATE icon
6
Fate Therapeutics
FATE
$275M
$12.6M 9.73%
2,473,186
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q3 2014 Portfolio in Review

As of Q3 2014, Polaris Venture Management Co V held 6 positions worth $130M, up 5.6% from $123M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V deployed $42.9M of net new capital in Q3 2014, opening 1 new position. Its largest new stake was T2 Biosystems, Inc: 475 shares worth $43M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 78% a quarter earlier.

On the sell side, the largest reduction was Genocea Biosciences, Inc., an estimated $1.01M trimmed.

  • Polaris Venture Management Co V's largest Q3 2014 buy was T2 Biosystems, Inc: 475 shares worth $43M.
  • Polaris Venture Management Co V's biggest Q3 2014 reduction was Genocea Biosciences, Inc., cutting an estimated $1.01M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $130M portfolio in Q3 2014.
  • Polaris Venture Management Co V opened 1 new position and closed 0 in Q3 2014.
  • Polaris Venture Management Co V's portfolio value rose 5.6% quarter-over-quarter to $130M.

Based on Polaris Venture Management Co V's 13F filing for Q3 2014, filed 23 Oct 2014.